Related Experiment Videos
[Pain therapy in pediatric oncology]
R Sittl1, N Griessnger, E Winter
1Klinik für Anästhesiologie, Universität Erlangen.
Fortschritte Der Medizin
|July 2, 1998
Summary
Pediatric malignancy-related pain management mirrors adult approaches, focusing on individualized therapy based on pain assessment. Treatment involves non-opioid analgesics, tramadol for moderate pain, and morphine for severe pain, with coanalgesics for neuropathic pain.
Area of Science:
- Oncology
- Pain Management
- Pediatrics
Context:
- Malignancy-related pain affects children and adolescents similarly to adults.
- Effective pain management is crucial for pediatric cancer patients.
- Individualized pain therapy requires thorough assessment of pain intensity, character, and location.
Purpose:
- To outline current strategies for managing malignancy-related pain in children and adolescents.
- To emphasize the importance of tailored pain treatment based on pathophysiological causes and pain severity.
- To discuss pharmacological and non-pharmacological interventions for pediatric cancer pain.
Summary:
- Pain assessment is the foundation for personalized pain therapy in pediatric oncology.
- Medication choices range from non-opioid analgesics to tramadol and morphine, guided by pain intensity.
- Neuropathic pain may require coanalgesics, and continuous parenteral morphine via pain pumps is an option when oral administration fails.
- Home-based parenteral opioid therapy is feasible with adequate medical support.
- Minimizing pain during diagnostic and therapeutic procedures is a key goal.
Impact:
- Improved quality of life for pediatric cancer patients through effective pain control.
- Standardized guidelines for pain management in pediatric oncology.
- Enhanced understanding of pharmacotherapy for cancer pain in young individuals.
- Facilitation of advanced pain management techniques, including home-based parenteral therapy.